20 studies found for:    "Pneumonia, Pneumococcal"
Show Display Options
RSS Create an RSS feed from your search for:
"Pneumonia, Pneumococcal"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated Ceftriaxone Vs Levofloxacin on Cytokine Expression in Pneumococcal Pneumonia
Condition: Pneumonia, Pneumococcal
Interventions: Drug: levofloxacin;   Drug: ceftriaxone
2 Completed New Antibiotic to Treat Patients With Community-acquired Pneumonia Due to a Specific Bacteria (S. Pneumoniae Pneumonia)
Conditions: Pneumonia, Pneumococcal;   Community Acquired Infections;   Gram-positive Bacterial Infections
Intervention: Drug: Antibiotic
3 Completed Epidemiologic Study Of The Distribution Of Vaccine-Type Streptococcus Pneumoniae Serotypes In Adults In The US With Community-Acquired Pneumonia
Conditions: Pneumonia, Pneumococcal;   Vaccines, Pneumococcal
Intervention: Procedure: Urine sample collection
4 Completed Targeting of Immune Response After Pneumococcal Vaccination
Condition: Pneumococcal Pneumonia
Interventions: Biological: Pneumococcal polysaccharide vaccine;   Biological: pneumococcal conjugate vaccine
5 Unknown  PCV10 Reactogenicity and Immunogenicity Study - Malindi
Condition: Pneumococcal Pneumonia
Interventions: Biological: PCV10 and DTaP;   Biological: hepatitis A vaccine, DTaP, PCV10
6 Completed Study Evaluating the Effiacy of a 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) in Adults
Conditions: Pneumonia, Pneumococcal;   Pneumococcal Infections;   13-valent Pneumococcal Vaccine
Interventions: Biological: VACCINE: placebo;   Biological: VACCINE: 13-valent pneumococcal conjugate vaccine
7 Recruiting Safety, Tolerability, and Efficacy Study of Prophylactic S. Pneumoniae Vaccine Following Challenge With S. Pneumoniae
Conditions: Pneumococcal Infections;   Pneumonia, Pneumococcal
Interventions: Biological: GEN-004 with Aluminum Hydroxide Adjuvant;   Biological: Placebo
8 Not yet recruiting Dose-Finding Study of S.Pneumoniae Whole Cell Vaccine Adsorbed to Alum (PATH-wSP) in Healthy Kenyan Adults and Toddlers
Condition: Pneumonia, Pneumococcal
Interventions: Biological: PATH-wSP;   Biological: pneumococcal polysaccharide conjugate vaccine (adsorbed);   Biological: Diptheria Pertussis Tetanus Hep B Haemophilus b Conjugate;   Other: Saline
9 Completed Study of Two Investigational Pneumococcal Vaccines in Healthy Adults
Conditions: Pneumococcal Infections;   Streptococcus Pneumoniae Infections;   Pneumococcal Pneumonia
Interventions: Biological: Pneumococcal Vaccine Formulation 1;   Biological: Pneumococcal Vaccine Formulation 2;   Biological: Pneumococcal Vaccine Formulation 3;   Biological: Pneumococcal Vaccine Formulation 4;   Biological: Pneumococcal Vaccine Formulation 5;   Biological: Placebo
10 Completed Study of an Investigational Pneumococcal Vaccine in Healthy Adult Volunteers
Conditions: Pneumococcal Infections;   Pneumococcal Pneumonia
Intervention: Biological: Pneumococcal Vaccine
11 Completed Study of an Investigational Pneumococcal Vaccine at Three Dose Levels in Healthy Adults
Conditions: Pneumococcal Infections;   Streptococcus Pneumoniae Infections;   Pneumococcal Pneumonia
Interventions: Biological: Pneumococcal vaccine Formulation 1;   Biological: Pneumococcal vaccine Formulation 2;   Biological: Pneumococcal vaccine Formulation 3;   Biological: Placebo
12 Completed PCV7 in the Prevention of Nasopharyngeal Carriage of Vaccine Serotype (VT) Streptococcus Pneumoniae
Conditions: Streptococcal Pneumonia;   Nasopharyngeal Diseases;   Vaccination Adverse Event
Interventions: Biological: PCV7 (Pneumococcal 7-Valent Conjugate Vaccine);   Biological: Hib Vaccine
13 Completed Delayed Antibiotic Treatment in Community-acquired Pneumococcal Pneumonia.
Condition: Community-acquired Pneumonia
Intervention: Procedure: Observation
14 Withdrawn Effect of Vaccination on Turnover of Lamivudine (3TC) Sensitive and Resistant Virus Populations in HIV-1-Infected Individuals
Condition: HIV Infections
Interventions: Biological: Influenza Virus Vaccine;   Biological: Pneumococcal Vaccine, Polyvalent (23-valent);   Drug: Lamivudine
15 Completed Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine
Condition: Pneumococcal Disease
Intervention: Biological: 10 valent pneumococcal conjugate (vaccine)
16 Completed Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.
Condition: Infections, Streptococcal
Intervention: Biological: 10 valent pneumococcal conjugate (vaccine)
17 Completed
Has Results
Immuno-Augmentation With GM-CSF of Pneumococcal Vaccine in Chronic Lymphocytic Leukemia Patients
Condition: Leukemia
Interventions: Drug: Sargramostim (GM-CSF);   Biological: Pneumococcal Vaccine
18 Completed Humoral Determinants of Immunity to Pneumococcal Infection
Conditions: Pneumonia;   Pneumococcal Infections;   Infections, Streptococcus Pneumoniae
Interventions: Biological: Prevnar;   Biological: Pneumovax
19 Completed Invasive Infections in Children With Hemoglobinopathies
Conditions: Thalassemia;   Sickle Cell Anemia
Intervention: Procedure: Historical records
20 Terminated Colombia Epidemiologic Surveillance Study
Conditions: Pneumonia;   Meningitis;   Bacteremia;   Sepsis
Intervention: Other: Surveillance

Indicates status has not been verified in more than two years